Nautilus Biotechnology, Inc. (NAUT) on GreekSoup https://greeksoup.ai/stocks/us/naut/ Every dated entry in the public record on Nautilus Biotechnology, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 Nautilus Biotechnology, Inc. Q3 FY2025 results: revenue $0, net income -$14 millionhttps://greeksoup.ai/stocks/us/naut/results/fy2025-q3/us:NAUT:result:2026-10-27:96aab82d16Tue, 27 Oct 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc. Q3 FY2026 results: revenue $234,000, net income -$16 millionhttps://greeksoup.ai/stocks/us/naut/results/fy2026-q3/us:NAUT:result:2026-10-27:32614a4833Tue, 27 Oct 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/naut/filings/us:NAUT:filing:2026-10-27:fe18c281d1Tue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/naut/filings/us:NAUT:filing:2026-10-27:255e6cd79fTue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: short interest 5,619,648 shares at the 15 October 2026 settlement, 1.00 days to coverhttps://greeksoup.ai/stocks/us/naut/short-interest/us:NAUT:short-interest:2026-10-15:0ad87522b8Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: short interest 5,771,054 shares at the 30 September 2026 settlement, 1.42 days to coverhttps://greeksoup.ai/stocks/us/naut/short-interest/us:NAUT:short-interest:2026-09-30:9e6ffd630fWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: short interest 4,082,014 shares at the 15 September 2026 settlement, 3.24 days to coverhttps://greeksoup.ai/stocks/us/naut/short-interest/us:NAUT:short-interest:2026-09-15:8abe362e9cTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc. filed 8-K: material agreement, termination of a material agreementhttps://greeksoup.ai/stocks/us/naut/filings/us:NAUT:filing:2026-09-11:337e054838Fri, 11 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: Schedule 13D/A filed by AH Bio Fund II, L.P., 4.9% of the classhttps://greeksoup.ai/stocks/us/naut/holders/us:NAUT:schedule-13:2026-09-11:2eb6ff8ac3Fri, 11 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: short interest 3,814,029 shares at the 31 August 2026 settlement, 6.44 days to coverhttps://greeksoup.ai/stocks/us/naut/short-interest/us:NAUT:short-interest:2026-08-31:d63fb1f78fMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: Schedule 13D/A filed by AH Bio Fund II, L.P., 6.0% of the classhttps://greeksoup.ai/stocks/us/naut/holders/us:NAUT:schedule-13:2026-08-28:4fd5cd156dFri, 28 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: Schedule 13D/A filed by Perceptive Advisors LLC, 9.1% of the classhttps://greeksoup.ai/stocks/us/naut/holders/us:NAUT:schedule-13:2026-08-14:352cb990e3Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Nautilus Biotechnology, Inc.: short interest 3,154,786 shares at the 14 August 2026 settlement, 3.67 days to coverhttps://greeksoup.ai/stocks/us/naut/short-interest/us:NAUT:short-interest:2026-08-14:31ecf63738Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>